This study evaluated whether lead acetate or other selected metal salts would influence the binding of L-tryptophan to rat hepatic nuclei. Lead salts and other salts of cadmium, zinc, mercury, and molybdenum, when added alone, had only small effects on 3 Htryptophan binding to hepatic nuclei in vitro. However, each of these salts, when added along with unlabeled L-tryptophan (excess, 10-4 M), caused significantly less inhibition of 3 H-tryptophan binding to hepatic nuclei than did unlabeled L-tryptophan alone. Lead acetate (10 -10 to 10-4 M), when added along with unlabeled L-tryptophan, abrogated the inhibition of binding related to unlabeled Ltryptophan alone. Sodium arsenite (but not potassium arsenate) as well as sodium selenite (at 10 -4 M concentrations) inhibited to a moderate degree the in vitro 3 H-tryptophan binding to hepatic nuclei, but addition of 10 -4 dithiothreitol, a protective agent for sulfhydryl groups, diminished this inhibition. Rats receiving a high dose of lead acetate before being tube-fed L-tryptophan displayed a decrease in hepatic protein synthesis compared with the stimulatory response connected with L-tryptophan alone. Thus, the addition of lead acetate and of other metal salts appears to have an inhibitory effect on L-tryptophan binding to hepatic nuclei. Lead acetate was investigated in in vivo experiments and was found to negate the stimulation of hepatic protein synthesis related to L-tryptophan alone.
INTRODUCTION
Our laboratory first reported on the unique action of tryptophan on hepatic polyribosomes and protein synthesis many years ago (27, 29) . The administration of tryptophan alone to mice or rats rapidly induced enhanced hepatic protein synthesis, whereas no other single amino acid had such an effect (29) . Others have confirmed the stimulatory effect of tryptophan on hepatic protein synthesis (3, 13, (19) (20) (21) (22) 24) . Subsequently, many studies concerned with the mechanism of the unique effect of tryptophan have revealed the following findings, which they claim are attributable to tryptophan: increased cytoplasmic mRNA(poly[A]mRNA) (15, 16) , probably related to increased translocation of mRNA from nuclei to cytoplasm (17, 18, 28) ; stimulation of the activities of enzymes associated with nuclear efflux of mRNA (14) and of nuclear poly(A)polymerase (10) ; and nuclear-envelope tryptophan binding and stimulation of poly(A)polymerase activity (10) , which appeared to be related to increased nuclear mRNA efflux (28) .
Our findings that hepatic nuclei had a specific receptor for L-tryptophan, which is saturable, stereospecific, and of high affinity (8, 9) , and that this receptor was similar to that described in mouse lymphoma (L5178g) cells (25) led us to suggest that the nuclear tryptophan receptor plays an important role in the sequence of events by which tryptophan acts to stimulate protein synthesis (9, 30, 32, 39) . Recently, we have found that the affinity for tryptophan to bind to its nuclear receptor may be altered by a variety of agents, factors, or conditions (30, 31, (33) (34) (35) (36) (37) (38) (39) (40) . The present study was designed to determine whether certain metallic salts could likewise influence the affinity of hepatic nuclear receptor tryptophan binding.
In earlier reports, a number of transition metals and their anions, such as lead, zinc, cadmium, arsenite, and selenite, have been demonstrated to affect nuclear binding of glucocorticoid (41, (44) (45) (46) . Also, in another study (35) , we demonstrated that selected hormones, such as 3,5,3'-triiodothyronine, hydrocortisone, and insulin, influence in vitro 3H-tryptophan binding to hepatic nuclei. Therefore, it became of interest to us to determine whether certain metal salts would affect nuclear tryptophan binding. This paper reports that a number of metals (cations) and their anions, many of which are toxic compounds, are able to inhibit the binding of L-tryptophan to hepatic nuclei in vitro.
MATERIALS AND METHODS
Animals. Female Sprague-Dawley rats (Hilltop Lab Animals, Scottdale, PA) weighing an average of 175 g were used in the experiments. The rats were fed a commercial diet (Rodent Lab Chow, Purina Mills, St. Louis, MO) and were maintained in a temperature-controlled room with alternating 12-hr light-dark cycles. Before beginning the experiments, the animals were fasted overnight, but they had free access to water.
Chemicals. The 3H-tryptophan was L-(5-3H)-tryptophan (1.13 TBq/mmol), and the 14C-leucine was (U-14C)Ieucine (12.9 GBq/mmol); both were from Amersham/Searle (Arlington Heights, IL). L-Tryptophan was obtained from U.S. Biochemical (Cleveland, OH), and other compounds were obtained from Sigma Chemical Co. (St. Louis, MO). Isolation of Nuclei. Rat hepatic nuclei were prepared as described by Blobel and Potter (2) . The liver tissue was minced and homogenized in 2 vol buffer A (0.05 M Tris~hydrochloride, pH 7.5; 0.025 M KCI; 0.005 M MgC'2; 0.0001 M phenylmethysulfonyl fluoride (PMSF); 0.0002 M dithiothreitol (DTT); and 0.25 M sucrose). The homogenate was filtered through cheesecloth (4 layers) before mixing with 2 vol buffer B (0.05 M Tris~hydrochloride, pH 7.5; 0.025 M KCI; 0.005 M MgC'2; and 2.3 M sucrose).
The latter was underlaid with 1 vol buffer B and centrifuged for 60 min at 105,000 X g in an ultracentrifuge (Model L5-75 Spinco, Beckman Instruments, Fullerton, CA). The supernatant was discarded, and the pellet was washed twice with buffer A before further use.
Preparation of Nuclear Envelopes. Nuclear envelopes were isolated according to the method of Agutter and Gleed (1), which is a modification of the technique described by Harris and Milne (6) , one that is routinely used in this laboratory (8, 9) . The purified nuclear envelopes were resuspended in a binding assay buffer C (0.05 M Tris~hydrochloride, pH 7.5; 0.002 M EDTA; 10% v/v glycerol; 0.001 M PMSF; and 0.002 M j3-mercaptoethanol).
Binding of 3H-Tryptophan to Nuclei or Nuclear Envelopes. Rat hepatic nuclei or nuclear envelopes prepared as described above were incubated with L-(5-3H)-tryptophan (277.5 kBq, 0.245 nmol L-tryptophan/assay) and were then added to the incubation mixture last at time 0 in the absence or presence of a 2,000-fold excess of unlabeled L-tryptophan ( 10-4 M) or test compound ( 10-4 M) at room temperature for 2 hr. Nuclei were then washed (by resuspension and centrifugation) 3 times with buffer A, and nuclear envelopes were washed 2 times with buffer C in order to remove free and loosely bound radioactivity. After the final wash, nuclei or nuclear envelopes were suspended in buffer A or buffer C, respectively, and then radioactivity was measured, after the addition of aqueous counting scintillation fluid (Opti-Fluor; Packard Instrument Co., Meriden, CT). Binding of 3H-tryptophan to hepatic nuclei or nuclear envelopes was expressed as counts per minute per unit of protein (binding in the absence of test compound minus binding in the presence of excess of test compound [10-4 M] ). Values were compared with values obtained using unlabeled L-tryptophan (control group). In some experiments, varying concentrations (10-14 to 10-~' M) of test compounds were used.
In Vitro Protein Synthesis. Microsomes prepared from postmitochondrial supernatants of livers from control and experimental rats were used for studies on incorporation in vitro, as described earlier (29) . In all assays, cytosols TABLE I.-Apparent inhibition of total in vitro 3H-tryptophan binding to hepatic nuclei using an excess of unlabeled L-tryptophan (Trp) or single salts alone or together.° Each compound was used at 10-1 M. In each experiment the water (control) group was set at 0% and the mean ± SEM of the binding was 21,263 ± 1,794 cpm/mg nuclear protein. ANOVA for the experimental groups using single compounds (Trp or salt), yielded an F ratio of 160 and p < 0.0001 and for the experimental groups using Trp alone or plus salt yielded an F = 59.8 and p < 0.0001. Pairwise comparisons were conduct using Dunn's (Bonferroni) correction.
Number of experiments are in parentheses. Values are mean ± SEM. ' p < 0.01, compared with water group. p < 0.01, compared with Trp group. e p < 0.05, compared with the water group. f p < 0.01, compared with the NaAS02 group.
(soluble fractions) of livers of control (distilled watertreated) rats were used. The cytosols were obtained by centrifugation of postmitochondrial supernatants at 40,000 revolutions/min for 2 hr in a 40 rotor in an ultracentrifuge (model L3-40, Beckman Instruments). L-(U-14C)Leucine (0.5 ~.Ci) was added to each incubation tube. The radioactivity in protein was measured using a liquid scintillation spectrometer (Beckman Instruments, Palo Alto, CA). The protein content was determined as described by Lowry et al (12) . Data were analyzed by analysis of variance or by Students's t-test (43) .
RESULTS
The first series of experiments was designed to determine whether total in vitro 3H-tryptophan binding to hepatic nuclei or to nuclear envelopes would be affected by the addition of selected metallic salts. Table I summarizes the data for such experiments. While the addition of excess unlabeled L-tryptophan ( 10-4 M) significantly inhibited total 3H-tryptophan binding to hepatic nuclei by 67.9%, most salts (except NaAsOz) at 10-4 M did not appreciably inhibit total 3H-tryptophan binding. When each salt (at 10-4 M) and unlabeled L-tryptophan ( 10-4 M) were added together to the in vitro binding assay, there was appreciable inhibition of binding to hepatic nuclei, except in the case of ZnSO 4,  , lead acetate (0-0), or both on 3H-tryptophan binding to rat hepatic nuclei. When both agents were used, in one case, L-tryptophan was kept constant at 10-4 M with variable levels of lead acetate (·---A), and in the second case, both were equally and simultaneously varied from 10-16 to 10-4 M (X-X). Each point is the mean ± SEM of the number of experiments (indicated by number adjacent to point). inhibition at 10-14 to 10-10 M. Tryptophan alone revealed progressively greater inhibition of binding with increasing concentrations of unlabeled tryptophan, with a 50% inhibition of specific 3H-tryptophan binding to hepatic nuclei (lC51) of 10-1 M, which is similar to findings reported earlier (8, 9) . When varying concentrations of lead acetate combined with a constant concentration of unlabeled tryptophan (10-4 M) were added, lead acetate at 10-14 to 10-4 M caused less inhibition than did unlabeled tryptophan alone, especially at the higher concentrations of lead acetate. When similar varying concentrations of lead acetate with varying concentrations of unlabeled tryptophan were added together, lead acetate at 10-14 to 10-1° M caused greater inhibition, but at 10-1 to 10-4 M they caused less inhibition, than did unlabeled tryptophan alone. This biphasic response indicates that the effect of lead acetate varies with the concentrations of both lead acetate and tryptophan. In 2 experiments, lead nitrate (10-4 M) was used alone or with unlabeled tryptophan ( 10-~ M), and the results were identical to those obtained with lead acetate ( 10-4 M). In one experiment, hepatic nuclear envelopes were used rather than hepatic nuclei, and the results of lead acetate alone at 10-12-10-8. and 10-4 M were similar to those obtained using hepatic nuclei.
In several experiments, we investigated whether varying concentrations of other salts, specifically cadmium chloride, mercurous nitrate, or sodium molybdate, would act similarly to the observed lead acetate results (Fig. 1 ). Using each of these salts at concentrations of 10-1° to 10-4 M combined with unlabeled tryptophan ( 10-4 M) , the curves of inhibition were somewhat different than those obtained with similar concentrations of lead acetate. The percents inhibition (and number of experiments completed in parentheses) of 3H-tryptophan binding to hepatic nuclei by cadmium chloride, mercurous nitrate, and sodium molybdate, respectively, at each concentration with constant tryptophan ( In view of the earlier findings that lead acetate affected in vitro 3H-tryptophan binding to hepatic nuclei (Table I  and Fig. 1 ), we next investigated whether the administration of a high dose of lead acetate to ovemight-fasted rats (control or tryptophan treated) would affect hepatic protein synthesis when we assayed in vitro after euthanatization of control and experimental (tryptophan-treated) rats. The results of these experiments are summarized in Table II . Tryptophan administration alone for 90 min caused a 70.7% enhancement of protein synthesis, whereas treatment with lead acetate alone for 90 or 120 min TABLE IL-In vitro &dquo;C-leucine incorporation into proteins of liver of rats treated with lead acetate. L-tryptophan, or both. a Rats fasted overnight and in the morning were treated as indicated. Water or tryptophan (30 mg per 100 g of body weight) were tube-fed while lead acetate (75 mg) was administered intraperitoneally. ANOVA for the experimental groups yielded an F ratio of 125 and a p value of 0.001. Pairwise comparisons were also made using the Dunn's (Bonferroni) correction.
The 100% represents 44,620 ± 16 .6% inhibition, respectively) (Table I) , we delved further into aspects of this finding. Since sodium arsenite alone (at 10-4 M) had an appreciable inhibitory effect on binding, other concentrations were studied. The results indicated the existence of the following percentages (number of experiments in parentheses) of inhibition in binding at each concentration of sodium arsenite: 10-3 M,
(3) 42.7 ± 3.62%; 10-5 M, (2) 39.5 -±-8.56%; 10-6 M, (6) 35.3 -!-2.74%; 10-g M, (4) 22.6 ± 4.62%; and 10-10 M, (4) 13.3 ± 5.05%. Thus, at low concentrations (up to 10 s M), there was appreciable inhibition of binding. Next, we determined whether the addition of high levels of DTT would affect the responses. In an earlier study on the effects of selenite and selenate on binding (31) , we reported that selenite but not selenate had an appreciable inhibitory effect on binding and that the addition of high levels of DTT to selenite prevented the inhibitory action on binding. This was explained on the following basis: selenite affected the binding site at the sulfhydryl sites of the nuclear receptor protein, and DTT, a protective agent for sulfhydryl groups, prevented the selenite response. b Means ± SEM. In each experiment the water (control) group was set at 0% and the mean ± SEM of the binding was 22,490 ± 423 cpm/mg nuclear protein. ANOVA for the expermental groups yielded an F ratio of 62.7 and p < 0.0001. Pairwise comparisons were also conducted using the Dunn's (Bonferroni) multiple comparison procedure.
< Results in this column are from an earlier paper (31 iment, we studied the effect of DTT on the lead acetateinduced effect on in vitro 3H-tryptophan binding in the presence of unlabeled tryptophan and observed essentially no change as a result of DTT.
In an earlier study, the KD and Bmax for 3H-tryptophan binding to rat hepatic nuclear envelopes were determined (8) . Also, the saturation isotherm for 3H-tryptophan binding using tryptophan (10-4 M) has been described (33) .
In this study, we were concerned with the effect of the addition of lead acetate on the saturation isotherm for 3Htryptophan binding. The results of 2 experiments, in which unlabeled tryptophan (10-4 M) alone or with lead acetate (10-10 or 10-1 M) were investigated with varying concentrations of 3H-tryptophan (0.38 to 15 RCi), are indicated in Fig. 2 . It is apparent that, at all of the concentrations of 3H-tryptophan, the addition of lead acetate (10-'° or 10-8 M) to the unlabeled tryptophan (10-4 M) diminished the specific binding to the hepatic nuclei.
DISCUSSION
Earlier reports have described that a number of metal cations have influenced steroid binding to glucocorticoid receptor (41, (44) (45) (46) . In most cases, salts of lead, zinc, cadmium, arsenite, and selenite have been inhibitory to such binding. In our present study, it appears that most of these salts, except selenite and arsenite, did not themselves appreciably compete with in vitro 3H-tryptophan binding to hepatic nuclei. However, all of these salts, except possibly ZnS04, when added to unlabeled excess tryptophan caused significantly less inhibition of 3H-tryptophan binding to hepatic nuclei than did unlabeled Ltryptophan alone. The mechanism(s) involved is, in most cases, not clear. With selenite and arsenite salts, it appears that they may act by affecting the tryptophan binding at the sulfhydryl sites in the nuclear receptor protein (31) .
Arsenite and selenite, but not arsenate and selenate, may act at the level of oxidation of sulfhydryl groups of the receptor, whereas DTT, a protective agent for sulfhydryl (SH) groups, can inhibit this process. Our findings with arsenite with and without DTT and with arsenate (Table   III ) on in vitro 3H-tryptophan binding to hepatic nuclei support this explanation. Thus, an effect, caused by some transition metals and their anions, on the thiol groups of the receptor protein may explain why some metallic salts affect 3H-tryptophan binding to rat hepatic nuclei. Indeed, the presence or absence of an intramolecular disulfide between a vicinally spaced pair of cysteine SH groups lying in the hormone-binding domain (4) has been demonstrated to be a determinant for steroid-binding activity of the glucocorticoid receptor. Using a number of SHmodifying agents, such as N-ethylmaleimide, iodoacetamide, p-chloromercuribenzoic acid, and methyl methane thiosulfonate, much information regarding the steroidbinding capacity of unliganded receptors was obtained (42) . Using iodoacetamide, p-chloromercuribenzoic acid, and methyl methane thiosulfonate, we found that the addition of each (at 10-4 M) caused a 20 to 26% inhibition of 3H-tryptophan binding to hepatic nuclei in vitro. Mercurial compounds, cadmium, sodium selenite, sodium arsenite, molybdate, and zinc (4, 42, 44, 45) have been considered to affect glucocorticoid receptor thiols and steroid binding activity. Nonetheless, one must consider that other toxic effects of the salts used in this study may play an as yet undefined role.
Toxicity related to a number of metals used in this study has been reported. As for lead, arsenic, and mercury, ingestion of high levels of such compounds can occur in a variety of ways. Recently, it has been reported that it may occur by using Asian patent medicines purchased in retail herbal stores (7) . Toxicity related to met-abolic effects on various organs, including the liver, has been described. Thus, a variety of metabolic alterations may occur. In this study, we focused our attention on alterations in receptor binding induced by metal salts. In view of our finding that lead acetate affects 3H-tryptophan binding to rat hepatic nuclei (Table I and Fig. 1 ), we searched the literature for effects of lead on other receptor binding. Most of the studies we found have dealt with the effect of high doses of lead on brain tissue, where it has been reported to be inhibitory to some receptors, such as growth hormone-releasing factor (11), synaptic membrane receptor binding of glutamate (23), dihydropyridine receptors (26) , and dopamine receptors (47) . Also, in liver, acute lead poisoning has been reported to decrease receptor density of benzodiazepine receptors, as measured by 3H-PK 11195 binding to liver membranes (5) . In each of these studies, the authors have considered how the effects of lead on important receptors may be involved or may play a role in lead toxicity.
In our present study, we have attempted to relate the effects that lead acetate has on hepatic nuclear tryptophan receptor binding with tryptophan's ability to stimulate protein synthesis. In rats, administration of a high dose of lead acetate alone caused a small decrease in hepatic protein synthesis, as determined by measuring in vitro 14C-leucine incorporation into hepatic protein (Table II ). Yet others have failed to describe a diminution of protein synthesis (48) . In our study, the diminution of the stimulatory response of hepatic protein synthesis related to tryptophan by lead acetate was much greater than the effect of lead acetate alone (Table III) . Thus, we consider that the adverse effect of the high dose of lead acetate on hepatic nuclear binding of tryptophan may relate to its negating the effect of tryptophan alone in normal animals. Tryptophan receptor binding has been considered to be a vital link in the enhancement of hepatic protein synthesis related to tryptophan (8, 30, 32, 39) .
Our present findings (that lead acetate alters the binding affinity of tryptophan to hepatic nuclei) closely resemble those reported earlier with L-leucine (33) . In each case, the compound itself does not appear to inhibit in vitro 3H-tryptophan binding to hepatic nuclei. However, when each was added together with unlabeled L-tryptophan, it abrogated the inhibitory effect that the unlabeled L-tryptophan alone had on binding. This effect occurred at low concentrations ( 10-~ M) of lead acetate or of Lleucine. This type of reaction pattern seems to be compatible with a response of an allosteric nature. At very low concentrations (<10-1° M) of lead acetate and of unlabeled L-tryptophan, the inhibitory effect on in vitro 3Htryptophan binding was greater than that associated with the unlabeled L-tryptophan alone (Fig. 1 ). Currently, we have no explanation for that effect, which suggests multiphase kinetics. The alterations in L-tryptophan binding to hepatic nuclei attributable to lead acetate or to L-leu-
